Related Experiment Video
Updated: Apr 18, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Charitable pharmacy services: Impact on patient-reported hospital use, medication access, and health status
Objective:
To evaluate the impact that Charitable Pharmacy of Central Ohio (CPCO), a pharmacy providing free pharmacy services and medications, had on an indigent patient population by determining the change in patient-reported hospital use, ability to access medications, and perception of health status after receiving CPCO services.
Design:
Cross-sectional study with face-to-face interviews using a convenience sample.
Setting:
Columbus, OH, in January to March 2013.
Patients:
206 English-speaking patients 18 years or older at CPCO.
Intervention:
Free pharmacy services and medications provided by CPCO.
Main Outcomes Measures:
Number of patient-reported hospital visits before and after CPCO use.
Results:
In the year before using CPCO, patients reported using the hospital a mean of 2.36 (median, 2.00) times per year versus 1.33 (median, 0.67) times per year after, a decrease of 1.03 hospital visits per year per patient. Before coming to CPCO, 41% of patients were able to have all of their prescribed medications filled; this rose to 85% after using CPCO. A total of 89% of patients reported that not only was their overall health was better, but they also had a better understanding of their medications and believed they were in more control of their own health since receiving CPCO services.
Conclusion:
A charitable pharmacy model has the potential to decrease health care costs and empower patients to be more in control of their health.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Drug Dosing: Geriatric Patients
Dosage Regimens: Partial Pharmacokinetic Parameters
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

